Serous papillary cystadenofibroma of the fallopian tube: A case report and short review of literature

Khatib, Yasmeen; Patel, Richa; Kashikar, Anuja; Chavan, Komal

doi:10.4103/0377-4929.168865

Cited by 6 publications

(8 citation statements)

References 8 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The last, nineteenth case of this tumor was reported in 2015 in a thirty-year-old woman who underwent surgery for a suspected ovarian tumor (16). Analyzing these cases, we find that CAF is most often in the form of a round solitary mass and that most are present at the fimbrial end of the tube.…”

Section: Discussionmentioning

confidence: 84%

“…Microscopic analysis of the vaginal portion of the uterus reveals a picture of slight dysplastic changes (CIN1). The cervical canal is Table 1 Reported cases of cystadenofibroma available in medical literature (2,3,(6)(7)(8)(9)(10)(11)(12)(13)(14)(15)(16) dominated by the image of chronic cervicitis. Cystic dilated follicles are seen in the sections of both ovaries.…”

Section: Case Reportmentioning

confidence: 99%

See 1 more Smart Citation

Papillary Cystadenofibroma of Fallopian Tube: Case Report with a Literature Review

et al. 2020

View full text Add to dashboard Cite

Introduction: Tumors of Fallopian tubes are rare in general, and they are the rarest tumors of female genital tract. According to clasification of World health organisation (WHO), papillomas, cystadenoma, adenofibroma, cystadenofibroma (CAF), metaplastic papillary tumors and endometrioid polyps belong to group of benign tumors. Serous papillary cystadenofibroma (SPCAF) is rare tumor and it is ususally located on fimbrial end of the tube and it is considered that it has "Müllerian" origin. Aim: The aim of this article is to show a rare case of cystadenofibroma of Fallopian tube which was found as random sample during histopathological analysis of specimen which was extracted during laparatomy due to the large tumor mass in abdomen. Case report: A 43-year-old patient underwent surgery for a large tumor mass in the abdomen, unknown lesions and pathohistology, which was radiologically verified four years before hospitalization. We removed the specimen that made up the tumor, along with the uterus and adnexes, weighing 14 kg and sent for histopatology. A large tumor mass is made up of a giant uterine myoma, and in the analysis of the other preparation, in addition to endometrial adenocarcinoma, there is also a rare Fallopian tube cystadenofibroma. On the sixth day of hospitalization, the patient is discharged home. At control after three months, the patient was without problems, with ongoing adjuvant brachytherapy. Conclusion: Improvement of prevention measures and work on the continuing education of patients and physicians at the primary care level are needed to ensure that patients receive the best treatment in a timely manner. Cystadenofibroma is a rare tumor in general and gynecologic oncology, and as authors it is a great honor for us to contribute to the world literature and to present the twentieth case of this tumor.

show abstract

Section: Discussionmentioning

confidence: 84%

Section: Case Reportmentioning

confidence: 99%

Papillary Cystadenofibroma of Fallopian Tube: Case Report with a Literature Review

et al. 2020

View full text Add to dashboard Cite

show abstract

“…Fallopian tube tumors are relatively uncommon tumors of the female genital tract, among which serous adenofibromas are benign and very unusual [ 1 – 3 ]. Only dozens of cases have been reported since 1909 [ 4 , 5 ]. Fallopian tube serous adenofibromas are mostly discovered incidentally during workup or surgery performed for other health issues [ 4 , 5 ].…”

Section: Introductionmentioning

confidence: 99%

“…Only dozens of cases have been reported since 1909 [ 4 , 5 ]. Fallopian tube serous adenofibromas are mostly discovered incidentally during workup or surgery performed for other health issues [ 4 , 5 ]. A review of literature of earlier cases with clinicopathological presentation of this tumor has recently been summarized [ 5 , 6 ].…”

Section: Introductionmentioning

confidence: 99%

“…Fallopian tube serous adenofibromas are mostly discovered incidentally during workup or surgery performed for other health issues [ 4 , 5 ]. A review of literature of earlier cases with clinicopathological presentation of this tumor has recently been summarized [ 5 , 6 ]. Clinical presentation of these tumors is usually asymptomatic, though a few cases present with symptoms of abdominal pain, palpable mass, vaginal bleeding and urinary or bowel symptoms [ 5 , 6 ].…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Disordered hypothalamus-pituitary-ovary axis in heterotopic extraovarian sex cord-stromal proliferation: a case report of fallopian tube serous adenofibroma

et al. 2023

View full text Add to dashboard Cite

Background Fallopian tube serous adenofibromas are uncommon tumors of the female genital tract, only dozens of cases have ever been reported. Earlier study indicated that they might be derived from embryonic remnants of the Müllerian duct. Clinical presentation of these tumors is usually asymptomatic. Small cysts of 0.5–3 cm in diameter are mostly incidentally found at the fimbriae end, with coarse papillary excrescences lined by epithelial cells and connective tissue stroma without nuclear pleomorphism or mitosis. Case presentation A 23-year-old woman with normal secondary sexual characters and 46, XX karyotype, presented to the gynecology clinic complaining of irregular menstrual cycles. Laboratory studies reported unique discrepancy of hormone levels; anti-Müllerian hormone (AMH): 6.05 ng/mL (The normal range of AMH is 1.70–5.63 ng/mL in women aged under 35 years old), follicle stimulating hormone (FSH): 31.9 mIU/mL (reference range: 3.85–8.78, follicular phase; 4.54–22.51, ovulatory phase; 1.79–5.12, luteal phase; 16.74-113.59, menopause), and luteinizing hormone (LH): 52.0 mIU/mL (reference range: 2.12–10.89, follicular phase; 19.18-103.03, ovulatory phase; 1.20-12.86, luteal phase; 10.87–58.64, menopause), mimicking gonadotropin-resistant ovary syndrome. The ultrasound reported a right adnexal cyst of 10.4 × 7.87 × 6.7 cm. Laparoscopic evaluation was performed; pathology revealed serous adenofibroma of the fallopian tube with ovarian stroma contents. Heterotopic extraovarian sex cord-stromal proliferations was most probable. The patient’s hormone levels returned to the reproductive status two weeks after surgery; FSH: 7.9 mIU/mL, LH: 3.59 mIU/mL,and AMH: 4.32 ng/mL. The patient’s menstrual cycles have resumed to normal for over two years after removal of the fallopian tube cyst. Conclusions This case of fallopian tube serous adenofibromas presented a discrepancy of serum AMH and FSH mimicking gonadotropin-resistant ovary syndrome. The clinical picture derived from heterotopic extraovarian sex cord-stromal proliferation indicated a disordered hypothalamus-pituitary-ovary axis.

show abstract

Benign Tumors, Pathology of the Fallopian Tube

Alvarado-Cabrero

2023

Encyclopedia of Pathology

View full text Add to dashboard Cite

Serous papillary cystadenofibroma of the fallopian tube: A case report and short review of literature

Cited by 6 publications

References 8 publications

Papillary Cystadenofibroma of Fallopian Tube: Case Report with a Literature Review

Papillary Cystadenofibroma of Fallopian Tube: Case Report with a Literature Review

Disordered hypothalamus-pituitary-ovary axis in heterotopic extraovarian sex cord-stromal proliferation: a case report of fallopian tube serous adenofibroma

Benign Tumors, Pathology of the Fallopian Tube

Contact Info

Product

Resources

About